Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-24 @ 9:28 PM
NCT ID:
NCT02356432
Eligibility Criteria:
Inclusion Criteria:
1. Diagnosis of NVAF
2. Diagnosis of cerebral infarction or TIA within 2 weeks after onset
3. Patients commenced on NOACs or warfarin therapy as a secondary prevention of cerebral infarction or transient ischemic attack, whether or not anticoagulation therapy was used before enrollment in this study
4. Age ≥20 years and ≤85 years
5. Ability to give valid consent and to provide consent in writing or availability of relatives to provide surrogate consent.
6. At least one CMB detected by 1.5 T MRI (T2\*WI) before enrollment in this study
Exclusion Criteria:
1. Patients using aspirin or other antiplatelet agents concomitantly
2. Patients in whom NOAC or warfarin is contraindicated
3. Patients with renal dysfunction (CrCL \<15 mL/min)
4. Patients with uncontrollable hypertension
5. Patients who are otherwise ineligible to take part in this study as judged by the study doctor
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
85 Years
Study:
NCT02356432
Study Brief:
Protocol Section:
NCT02356432